To align with international cutting-edge trends and expand the global cooperation landscape, from May 5 to 7, 2026, Zhengzhou Linnuo Pharmaceutical Co., Ltd. (hereinafter referred to as "Linnuo Pharmaceutical") made its debut at Vitafoods Europe 2026 with innovative R&D achievements and a full-industry-chain solution. At the Fira Gran Via venue in Barcelona, Spain, Linnuo Pharmaceutical explored new trends in the global health industry and built a new cooperation ecosystem with elite professionals from around the world!

A Global Benchmark Event Witnessing Industrial Strength

As a bellwether of the global nutritional and health food industry, Vitafoods Europe has become a highly authoritative and influential professional exhibition in Europe and even globally since its founding in 1997 after nearly 30 years of development. It serves as a core platform to access the EU's €480 billion health market. The 2026 exhibition has been fully upgraded, with the exhibition area expanded by 20% and extended to 4 exhibition halls for the first time. It has attracted more than 1,600 top global exhibitors and over 30,000 professional visitors to gather in Barcelona, covering more than 135 countries. More than 95% of the attendees are procurement decision-makers, accurately radiating core global markets such as Europe, Asia, and the Americas.

With "sustainable development, precision nutrition, plant-based innovation, and digital health" as the core tracks, this exhibition focuses on cutting-edge trends including gut health, GLP-1 applications, and ingestible beauty. It provides enterprises with a one-stop platform for technical exchanges, product displays, and business docking, and is also a golden window for Chinese enterprises to expand overseas markets and convey Oriental health wisdom.

Linnuo's Strength Shines, Demonstrating China's Intelligent Manufacturing

As a high-tech enterprise deeply engaged in the health industry for 17 years, Linnuo Pharmaceutical was founded in 2009 and is located in Zhengzhou High-tech Zone. It is a full-industry-chain enterprise integrating R&D, production, sales, and services. It possesses complete qualifications such as customs import and export qualification, health food filing, and special dietary food filing, and has passed international authoritative system certifications including US FDA, HACCP, ISO9001, ISO22000, and GMP. Its products are well-sold in countries and regions such as the United States, Europe, and Southeast Asia.

In this exhibition, Linnuo Pharmaceutical focused on displaying various dosage forms including compressed candies, hard capsules, soft capsules, powders, and plant-based beverages. Relying on 100,000-class clean workshops, a professional production team of more than 300 people, and mature one-stop OEM/ODM service capabilities, Linnuo Pharmaceutical adheres to the strict concept of "producing food to pharmaceutical standards" and strictly controls quality throughout the entire chain from raw material procurement to finished product delivery. With rich industry experience, outstanding R&D strength, and efficient production capacity, it has become a trusted partner for global customers.

During the exhibition, the Linnuo Pharmaceutical team conducted in-depth exchanges with industry colleagues from Spain, France, Germany, Italy and other countries, accurately matched the European market demand and regulatory standards, and elaborated on product formulas, production processes, quality control and customized cooperation solutions. A number of cooperation intentions were reached on site, laying a solid foundation for further exploring the European market. Meanwhile, the team actively learned about international cutting-edge technologies, innovative dosage forms and sustainable packaging concepts, gained in-depth insights into industry hot trends such as precision nutrition, gut health and plant-based products, injecting new impetus into the enterprise's technological upgrading and product innovation.

Deepen Global Layout, Build a Healthy Future Together

Participating in Vitafoods Europe 2026 is an important step in Linnuo Pharmaceutical's internationalization strategy, and also a vivid practice of the enterprise integrating into the global health industry with an open attitude and demonstrating the strength of China's health intelligent manufacturing. From deep cultivation in the domestic market to expansion of the global territory, relying on the in-depth integration of industry, university and research with the Traditional Chinese Medicine Health Research Institute and Postdoctoral Workstation, the enterprise continues to increase scientific research investment, break through key technical bottlenecks, promote the in-depth integration of traditional medicinal and edible homology culture with modern nutritional technology, and create health products that combine Oriental wisdom with international standards.

In the future, taking this European exhibition as an opportunity, Linnuo Pharmaceutical will continue to deepen its global layout, actively expand international cooperation channels, continuously enhance the core competitiveness and international influence of its products, meet the global consumers' demand for a healthy life with higher-quality products and more professional services, and contribute China's strength to promoting the high-quality development of the global health industry!